Literature DB >> 34018042

Laparoscopic Versus Open Incisional Hernia Repair: Long-Term Follow-up Results of a Randomized Clinical Trial.

Francisco Asencio1,2, Juan Carbó3,4, Ramón Ferri3,5, Salvador Peiró3,6,7, Javier Aguiló3,5, Inmaculada Torrijo8,3, Sebastian Barber3,4, Raul Canovas8,3, Juan Carlos Andreu-Ballester8,3.   

Abstract

PURPOSE: Long-term extension of a previous randomized controlled clinical trial comparing open (OVHR) vs. laparoscopic (LVHR) ventral hernia repair, assessing recurrence, reoperation, mesh-related complications and self-reported quality of life with 10 years of follow-up.
METHODS: Eighty-five patients were followed up to assess recurrence (main endpoint), reoperation, mesh complications and death, from the date of index until recurrence, death or study completion, whichever was first. Recurrence, reoperation rates and death were estimated by intention to treat. Mesh-related complications were only assessed in the LVHR group, excluding conversions (intraperitoneal onlay; n = 40). Quality of life, using the European Hernia Society Quality of Life score, was assessed in surviving non-reoperated patients (n = 47).
RESULTS: The incidence rates with 10 person-years of follow-up were 21.01% (CI 13.24-33.36) for recurrence, 11.92% (CI: 6.60-21.53) for reoperation and 24.88% (CI 16.81-36.82) for death. Sixty-two percent of recurrences occurred within the first 2 years of follow-up. No significant differences between arms were found in any of the outcomes analyzed. Incidence rate of intraperitoneal mesh complications with 10 person-years of follow-up was 6.15% (CI 1.99-19.09). The mean EuraHS-QoL score with 13.8 years of mean follow-up for living non-reoperated patients was 6.63 (CI 4.50-8.78) over 90 possible points with no significant differences between arms.
CONCLUSION: In incisional ventral hernias with wall defects up to 15 cm wide, laparoscopic repair seems to be as safe and effective as open techniques, with no long-term differences in recurrence and reoperation rates or global quality of life, although lack of statistical power does not allow definitive conclusions on equivalence between alternatives. TRIAL REGISTRATION NUMBER: ClinicalTrial.gov (NCT04192838).
© 2021. Société Internationale de Chirurgie.

Entities:  

Mesh:

Year:  2021        PMID: 34018042     DOI: 10.1007/s00268-021-06164-7

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  4 in total

Review 1.  Low-dose rate brachytherapy for men with localized prostate cancer.

Authors:  Frank Peinemann; Ulrich Grouven; Lars G Hemkens; Carmen Bartel; Holger Borchers; Michael Pinkawa; Axel Heidenreich; Stefan Sauerland
Journal:  Cochrane Database Syst Rev       Date:  2011-07-06

Review 2.  Laparoscopic versus open incisional and ventral hernia repair: a systematic review and meta-analysis.

Authors:  Yanyan Zhang; Haiyang Zhou; Yunsheng Chai; Can Cao; Kaizhou Jin; Zhiqian Hu
Journal:  World J Surg       Date:  2014-09       Impact factor: 3.352

3.  Laparoscopic repair of incisional abdominal hernias using expanded polytetrafluoroethylene: preliminary findings.

Authors:  K A LeBlanc; W V Booth
Journal:  Surg Laparosc Endosc       Date:  1993-02

Review 4.  Incisional Hernia Rates After Laparoscopic or Open Abdominal Surgery-A Systematic Review and Meta-Analysis.

Authors:  Julia B Kössler-Ebs; Kathrin Grummich; Katrin Jensen; Felix J Hüttner; Beat Müller-Stich; Christoph M Seiler; Phillip Knebel; Markus W Büchler; Markus K Diener
Journal:  World J Surg       Date:  2016-10       Impact factor: 3.352

  4 in total
  2 in total

1.  Endoscopic transversus abdominis release in the treatment of midline incisional hernias: a prospective single-center observational study on 100 patients.

Authors:  V Burdakov; A Zverev; N Matveev
Journal:  Hernia       Date:  2022-07-20       Impact factor: 2.920

2.  A prospective, multicenter trial of a long-term bioabsorbable mesh with Sepra technology in cohort of challenging laparoscopic ventral or incisional hernia repairs (ATLAS trial).

Authors:  William W Hope; Adel G El-Ghazzawy; Brad A Winterstein; Jeffrey A Blatnik; S Scott Davis; Jacob A Greenberg; Noel C Sanchez; Eric M Pauli; Daniel M Tseng; Karl A LeBlanc; Kurt E Roberts; Curtis E Bower; Eduardo Parra-Davila; J Scott Roth; Corey R Deeken; Eric F Smith
Journal:  Ann Med Surg (Lond)       Date:  2021-12-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.